KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Merck (MRK) Non Operating Income (2016 - 2025)

Merck (MRK) has disclosed Non Operating Income for 16 consecutive years, with -$432.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Non Operating Income fell 240.16% to -$432.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$389.0 million, a 363.1% decrease, with the full-year FY2025 number at -$151.0 million, down 729.17% from a year prior.
  • Non Operating Income was -$432.0 million for Q4 2025 at Merck, down from $7.0 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $448.0 million in Q1 2021 to a low of -$432.0 million in Q4 2025.
  • A 4-year average of -$18.8 million and a median of -$60.0 million in 2023 define the central range for Non Operating Income.
  • Biggest YoY gain for Non Operating Income was 116.67% in 2025; the steepest drop was 240.16% in 2025.
  • Merck's Non Operating Income stood at $448.0 million in 2021, then plummeted by 117.41% to -$78.0 million in 2023, then crashed by 62.82% to -$127.0 million in 2024, then tumbled by 240.16% to -$432.0 million in 2025.
  • Per Business Quant, the three most recent readings for MRK's Non Operating Income are -$432.0 million (Q4 2025), $7.0 million (Q2 2025), and -$127.0 million (Q4 2024).